Has Pramod Yadhati, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,883 in general payments to Pramod Yadhati, MD across 62 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Pramod Yadhati, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Pramod Yadhati, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Pramod Yadhati, MD

Pain Medicine · Wilmington, DENPI 1306993316

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Medtronic at 50.0% of the total. Reporting peaked in 2020 at $416 and has fallen 78.6% since, to $89 in 2025. That places this record below the midpoint for pain medicine clinicians in DE, where the typical reported total is $3,435.

$1,883in general payments, 2019–2025

Across 62 payments — averaging $30.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$941
Stimwave Technologies Incorporated$137
Curonix LLC$98
Electronic Waveform Lab, Inc.$87
Scilex Pharmaceuticals Inc.$85
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$82
plus $453 from 15 others

What the payments were for

Food & beverage$1,883100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	20	$941
Stimwave Technologies Incorporated	4	$137
Curonix LLC	1	$98
Electronic Waveform Lab, Inc.	3	$87
Scilex Pharmaceuticals Inc.	4	$85
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$82
Biodelivery Sciences International, Inc.	1	$75
Arbor Pharmaceuticals, Inc.	4	$59
Kowa Pharmaceuticals America, Inc.	3	$43
Boston Scientific	2	$39
Abbott	2	$33
Azurity Pharmaceuticals, Inc.	2	$33
Pacira Therapeutics, Inc.	1	$28
Pfizer	2	$27
West Therapeutics Development, LLC	2	$24
Vertos Medical, Inc.	1	$23
Nevro Corp.	1	$17
Bioventus LLC	1	$16
Amgen	1	$13
Almatica Pharma LLC	1	$12
AstraZeneca	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,883 in reported general payments places this provider in the 30th percentile of 31 pain medicine providers in Delaware.

See all pain medicine providers in Delaware →

Medicare billing

Part B allowed, 2024

$69,993

Medicare patients

101

Services billed

727

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OxycontinOxycodone Hcl	11	$11,260
Morphine Sulfate ErMorphine Sulfate	179	$4,870
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	185	$3,066
Fentanyl	22	$2,983
Gabapentin	202	$2,501
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	103	$2,365
Oxycodone Hcl	147	$1,604
Tramadol Hcl ErTramadol Hcl	24	$1,351
Morphine Sulfate	64	$1,120
Tizanidine Hcl	67	$435
Ibuprofen	32	$296
Cyclobenzaprine Hcl	20	$233
Tramadol Hcl	27	$202
Naproxen	13	$191
Duloxetine Hcl	20	$140

Paid to pharmacies, not to this prescriber.

Other pain medicine in Wilmington

Selina XingWilmington$13K
Alexander MatzWilmington$6K
Daniel NasrWilmington$6K
Sriniketh SundarWilmington$5K
Amir Abdel KaderWilmington$5K
Chiedozie UwanduWilmington$4K
Jason RothWilmington$4K
Manny LaiWilmington$4K
Chee WooWilmington$3K
Yasmin ElkhashabWilmington$2K

See the full list for Delaware →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →